New transplant trial aims to 'Reboot' faulty immune systems
NCT ID NCT03663933
Summary
This study is testing whether a transplant of healthy blood-forming stem cells from a donor can safely give people with serious T-cell immune disorders a new, working immune system. The goal is to control these often life-threatening conditions by replacing the faulty immune cells. Participants receive chemotherapy and medications to prepare their body for the transplant and to prevent complications afterward.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMMON VARIABLE IMMUNODEFICIENCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
-
National Marrow Donor Program
Minneapolis, Minnesota, 55401, United States
Conditions
Explore the condition pages connected to this study.